W F Anderson

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Declining second primary ovarian cancer after first primary breast cancer
    Sara J Schonfeld
    Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA
    J Clin Oncol 31:738-43. 2013
  2. pmc Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study
    Bassam Ghabach
    Department of Veterans Affairs Medical Center, Medical Service 111, 921 NE 13th Street, Oklahoma City, OK 73104, USA
    Breast Cancer Res 12:R54. 2010
  3. ncbi request reprint Is male breast cancer similar or different than female breast cancer?
    William F Anderson
    NCI Division of Cancer Prevention, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 83:77-86. 2004
  4. ncbi request reprint Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma
    William F Anderson
    Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 13:1128-35. 2004
  5. pmc Age-period-cohort models in cancer surveillance research: ready for prime time?
    Philip S Rosenberg
    Cancer Epidemiol Biomarkers Prev 20:1263-8. 2011
  6. ncbi request reprint Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers
    William F Anderson
    Biostatistics Branch, DHHS NIH NCI DCEG, EPS, Bethesda, MD 20892 7244, USA
    Cancer Causes Control 18:1187-98. 2007
  7. ncbi request reprint Shifting breast cancer trends in the United States
    William F Anderson
    Biostatistics Branch, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD 20892 7244, USA
    J Clin Oncol 25:3923-9. 2007
  8. ncbi request reprint Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome
    William F Anderson
    DHHS NIH NCI Division of Cancer Prevention, EPN Suite 2144, 6130 Executive Blvd, Bethesda, MD, 20892, USA
    Breast Cancer Res Treat 90:127-37. 2005
  9. pmc Epidemiology of inflammatory breast cancer (IBC)
    William F Anderson
    DHHS NIH NCI DCP, Rockville, MD 20852 7244, USA
    Breast Dis 22:9-23. 2005
  10. ncbi request reprint In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20852 3342, USA
    Cancer 104:1733-41. 2005

Detail Information

Publications84

  1. pmc Declining second primary ovarian cancer after first primary breast cancer
    Sara J Schonfeld
    Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA
    J Clin Oncol 31:738-43. 2013
    ..Although ovarian cancer incidence rates have declined in the United States, less is known of ovarian cancer trends among survivors of breast cancer. Therefore, we examined second primary ovarian cancers after first primary breast cancer...
  2. pmc Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study
    Bassam Ghabach
    Department of Veterans Affairs Medical Center, Medical Service 111, 921 NE 13th Street, Oklahoma City, OK 73104, USA
    Breast Cancer Res 12:R54. 2010
    ..We sought to provide new population-based information on breast-ACC incidence, relative survival, and associated cancer risk in the United States...
  3. ncbi request reprint Is male breast cancer similar or different than female breast cancer?
    William F Anderson
    NCI Division of Cancer Prevention, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 83:77-86. 2004
    ..To determine if male breast carcinogenesis was similar to its more common female counterpart, we compared incidence patterns among men and women with breast cancer...
  4. ncbi request reprint Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma
    William F Anderson
    Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 13:1128-35. 2004
    ..In this analysis, our objective was to compare age-specific incidence rate patterns for different morphologic types of breast carcinoma...
  5. pmc Age-period-cohort models in cancer surveillance research: ready for prime time?
    Philip S Rosenberg
    Cancer Epidemiol Biomarkers Prev 20:1263-8. 2011
    ..We illustrate these principles by using invasive female breast cancer incidence in the United States, but these concepts apply equally well to other cancer sites for incidence or mortality...
  6. ncbi request reprint Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers
    William F Anderson
    Biostatistics Branch, DHHS NIH NCI DCEG, EPS, Bethesda, MD 20892 7244, USA
    Cancer Causes Control 18:1187-98. 2007
    ..Prior to 1999-2000, breast cancer incidence rates had risen for decades, though more among older than younger women...
  7. ncbi request reprint Shifting breast cancer trends in the United States
    William F Anderson
    Biostatistics Branch, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD 20892 7244, USA
    J Clin Oncol 25:3923-9. 2007
    ..United States breast cancer incidence rates declined during the years 1999 to 2003, and then reached a plateau. These recent trends are impressive and may indicate an end to decades of increasing incidence...
  8. ncbi request reprint Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome
    William F Anderson
    DHHS NIH NCI Division of Cancer Prevention, EPN Suite 2144, 6130 Executive Blvd, Bethesda, MD, 20892, USA
    Breast Cancer Res Treat 90:127-37. 2005
    ..Standard tumor characteristics are used to predict initial relapse or death, but their ability to estimate long-term patterns of failure may be limited...
  9. pmc Epidemiology of inflammatory breast cancer (IBC)
    William F Anderson
    DHHS NIH NCI DCP, Rockville, MD 20852 7244, USA
    Breast Dis 22:9-23. 2005
    ..We also incorporate emerging data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program...
  10. ncbi request reprint In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20852 3342, USA
    Cancer 104:1733-41. 2005
    ..In situ breast carcinoma is not so well characterized for men as for women...
  11. ncbi request reprint Comparison of age distribution patterns for different histopathologic types of breast carcinoma
    William F Anderson
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, EPS, Room 8036, 6120 Executive Boulevard, Bethesda, MD 20892 7244, USA
    Cancer Epidemiol Biomarkers Prev 15:1899-905. 2006
    ..More recent studies, however, have shown distinct age incidence patterns for female breast cancer when stratified by estrogen receptor (ER) expression and/or histopathologic subtypes, suggesting etiologic heterogeneity...
  12. ncbi request reprint Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Executive Plaza South 8070, 6120 Executive Plaza Blvd, Rockville, MD 20892 7242, USA
    Cancer Causes Control 18:439-47. 2007
    ..Clarifying age-specific female breast cancer risks and interactions may provide important etiologic clues...
  13. ncbi request reprint Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer
    William F Anderson
    DHHS NIH NCI Division of Cancer Epidemiology and Genetics, Biostatistics Branch, EPS, Room 8036, 6120 Executive Blvd, Rockville, MD 20852 7244, USA
    Breast Cancer Res Treat 100:121-6. 2006
    ..We hypothesized that annual mortality rates from breast cancer after initial diagnosis (hazard rates) might also vary by ER and histopathology...
  14. ncbi request reprint Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002)
    William F Anderson
    Biostatistics Branch, Principal Investigator, DHHS NIH NCI Division of Cancer Epidemiology and Genetics, EPS, Room 8036, 6120 Executive Blvd, Rockville, MD 20852 7244, USA
    Breast Cancer Res Treat 99:333-40. 2006
    ..Though the ultimate goal of screening is to reduce breast cancer deaths, the immediate goal is to detect and treat early-stage tumors before they pose a threat to life...
  15. pmc Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program
    W F Anderson
    NIH NCI DCEG, EPS Room 8036, 6120 Executive Blvd, Bethesda, MD 20852, USA
    Breast Cancer Res Treat 113:189-96. 2009
    ..To validate the utility of the RTR for supplementing SEER's central database, we assessed human epidermal growth factor receptor-2 (HER2) and estrogen receptor expression (ER) in a demonstration project...
  16. ncbi request reprint Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
    William F Anderson
    National Cancer Institute, Division of Cancer Prevention, EPN, Room 2144, 6130 Executive Blvd, Bethesda, MD 20892 7317, USA
    J Clin Oncol 21:2254-9. 2003
    ..Inflammatory breast carcinoma (IBC) and noninflammatory locally advanced breast carcinoma (LABC) are both associated with poor prognosis; however, whether they are distinct clinicopathologic entities remains controversial...
  17. pmc Incidence of breast cancer in the United States: current and future trends
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Biostatistics Branch, Executive Plaza South, Rm 8036, 6120 Executive Blvd, Bethesda, MD, USA
    J Natl Cancer Inst 103:1397-402. 2011
    ..Time trends provide important clues for cancer etiology and prevention; however, the observed trends of ER-positive and ER-negative breast cancers can be biased by missing ER data...
  18. ncbi request reprint Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database
    W F Anderson
    Division of Cancer Prevention, Office of Special Population Research, and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7161, USA
    J Clin Oncol 19:18-27. 2001
    ..Determining whether hormone receptor expression represents one or more breast cancer phenotypes would have important paradigmatic and practical implications...
  19. pmc Male breast cancer: a population-based comparison with female breast cancer
    William F Anderson
    Biostatistics Branch BB, DHHS NIH NCI Division of Cancer Epidemiology and Genetics DCEG, EPS, Room 8036, 6120 Executive Blvd, Bethesda, MD 20892 7244, USA
    J Clin Oncol 28:232-9. 2010
    ..Because of its rarity, male breast cancer is often compared with female breast cancer...
  20. pmc Age-related crossover in breast cancer incidence rates between black and white ethnic groups
    William F Anderson
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, United States Department of Health and Human Services, Bethesda, MD 20892 7244, USA
    J Natl Cancer Inst 100:1804-14. 2008
    ..This crossover in incidence rates between black and white ethnic groups has been well described, has not been completely understood, and has been viewed as an artifact...
  21. ncbi request reprint Colorectal cancer screening for persons at average risk
    William F Anderson
    Division of Cancer Prevention Gastrointestinal and Other Cancer Research Group, National Cancer Institute, Bethesda, MD 20892 7117, USA
    J Natl Cancer Inst 94:1126-33. 2002
  22. pmc Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma
    William F Anderson
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20892 7244, USA
    Cancer 115:4176-85. 2009
    ..However, numerous questions remain regarding the timing and/or age of exposure...
  23. ncbi request reprint Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database
    William F Anderson
    NCI Division of Cancer Prevention, EPN, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 76:27-36. 2002
    ..Researchers question whether estrogen receptor alpha-negative (ERN) and -positive (ERP) represent different stages of one disease or different breast cancer types...
  24. pmc Established breast cancer risk factors by clinically important tumour characteristics
    M Garcia-Closas
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20852 7234, USA
    Br J Cancer 95:123-9. 2006
    ..In conclusion, these data support distinctive risk factor relationships by tumour characteristics of prognostic relevance. These findings might be useful in developing targeted prevention efforts...
  25. ncbi request reprint Breast cancer trends among black and white women in the United States
    Ismail Jatoi
    Department of Surgery, National Naval Medical Center, Bethesda, MD 20814, USA
    J Clin Oncol 23:7836-41. 2005
    ..Calendar period mortality trends reflect the effects of new medical interventions, whereas birth cohort mortality trends reflect alterations in risk factors...
  26. pmc Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
    Porcia T Bradford
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 113:5064-73. 2009
    ..7. This recent apparent change could be incomplete case ascertainment or potential leveling off of IRs. CLs rates vary markedly by race and sex, supporting the notion that they represent distinct disease entities...
  27. ncbi request reprint Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups
    K C Chu
    Center to Reduce Cancer Health Disparities, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7161, USA
    Cancer 92:37-45. 2001
    ..The current study reports on some of these data for eight racial/ethnic groups...
  28. ncbi request reprint Cancer screening
    Ismail Jatoi
    Department of Surgery, National Naval Medical Center, Uniformed Services University, Bethesda, MD, USA
    Curr Probl Surg 42:620-82. 2005
  29. pmc Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy
    G M Dores
    Medical Service, Department of Veterans Affairs Medical Center, 921 N E 13th Street, Oklahoma City, OK 73104, USA
    Br J Cancer 103:1081-4. 2010
    ..It is unknown whether breast cancer (BC) characteristics among young women treated with radiotherapy (RT) for Hodgkin's lymphoma (HL) differ from sporadic BC...
  30. doi request reprint Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma
    Neil E Caporaso
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Cancer J 15:117-23. 2009
    ..These results emphasize an interaction between environmental and genetic risk factors in HL...
  31. doi request reprint Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
    Anil K Chaturvedi
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    J Clin Oncol 26:612-9. 2008
    ....
  32. pmc Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005
    Sam M Mbulaiteye
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics DCEG, National Cancer Institute, Bethesda, MD 20852, USA
    Int J Cancer 126:1732-9. 2010
    ..To our knowledge, tri/bimodal incidence patterns have not previously been reported for BL. Trimodal/bimodal BL suggests heterogeneity in etiology or biology of BL diagnosed at different ages in males and females...
  33. pmc Gender is an age-specific effect modifier for papillary cancers of the thyroid gland
    Briseis A Kilfoy
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20852 7244, USA
    Cancer Epidemiol Biomarkers Prev 18:1092-100. 2009
    ..There are few known thyroid cancer risk factors except female gender, and the reasons for the increasing incidence and gender differences are unknown...
  34. ncbi request reprint Differences in risk factors for breast cancer molecular subtypes in a population-based study
    Xiaohong R Yang
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Room 7014, 6120 Executive Boulevard, Bethesda, MD 20892 7236, USA
    Cancer Epidemiol Biomarkers Prev 16:439-43. 2007
    ..Results from this study have shown that breast cancer risk factors may vary by molecular subtypes identified in expression studies, suggesting etiologic, in addition to clinical, heterogeneity of breast cancer...
  35. ncbi request reprint Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis
    Ismail Jatoi
    Department of Surgery, National Naval Medical Center and Uniformed Services, University of the Health Sciences, Bethesda, MD 20814, USA
    J Clin Oncol 25:1683-90. 2007
    ..However, the efficacy of these modalities may depend on estrogen receptor (ER) expression and age. We therefore examined breast cancer mortality trends in the United States according to ER status and age...
  36. doi request reprint Hairy cell leukaemia: a heterogeneous disease?
    Graca M Dores
    Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA
    Br J Haematol 142:45-51. 2008
    ..Distinct early- and late-onset HCL populations may reflect different age-related causal pathways, risk factor profiles, and/or stem cells of origin...
  37. ncbi request reprint Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis
    Mark E Sherman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Int J Cancer 121:1079-85. 2007
    ..07) for low PR and HER2 expression vs. OR = 1.78 (95% CI = 1.25-2.55) for high expression (p-heterogeneity = 0.001). PR and HER2 levels in breast cancer vary by BMI, suggesting a heterogeneous etiology for tumors related to these markers...
  38. ncbi request reprint Early- and late-onset breast cancer types among women in the United States and Japan
    Rayna K Matsuno
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 6120 Executive Boulevard, Room 8105, Rockville, MD 20852 7244, USA
    Cancer Epidemiol Biomarkers Prev 16:1437-42. 2007
    ....
  39. pmc Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis
    Idan Menashe
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852 7244, USA
    J Natl Cancer Inst 101:993-1000. 2009
    ..In the United States, a black-to-white disparity in age-standardized breast cancer mortality rates emerged in the 1980s and has widened since then...
  40. ncbi request reprint Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
    Graca M Dores
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services DHHS, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Br J Haematol 139:809-19. 2007
    ..Avenues of future research include assessment of delayed- and under-reporting to cancer registries and exploration of race, gender, and age effects in epidemiological studies...
  41. doi request reprint Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics
    Jonine D Figueroa
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Breast Cancer Res Treat 121:727-35. 2010
    ..These results warrant analysis in studies of clinical outcomes accounting for age, ER status and treatment...
  42. ncbi request reprint Merkel cell carcinoma and multiple primary cancers
    Regan A Howard
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006
    ..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition...
  43. pmc Recent trends in breast cancer among younger women in the United States
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, MD 20852 7234, USA
    J Natl Cancer Inst 100:1643-8. 2008
    ..Continued surveillance of trends is needed, particularly for molecular subtypes that preferentially occur among young women...
  44. ncbi request reprint Colorectal carcinoma in black and white race
    William F Anderson
    National Cancer Institute Division of Cancer Prevention Gastrointestinal Cancer and Other Cancers Research Group, Bethesda, Maryland, USA
    Cancer Metastasis Rev 22:67-82. 2003
    ..Racial variations demonstrate the need for a more comprehensive understanding of colorectal carcinogenesis, epidemiology, and colorectal screening patterns for low- and high-risk populations...
  45. ncbi request reprint Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups
    Kenneth C Chu
    Center to Reduce Cancer Health Disparities, National Cancer Institute, Bethesda, MD 20892 8341, USA
    Breast Cancer Res Treat 74:199-211. 2002
    ....
  46. ncbi request reprint Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications
    William F Anderson
    DHHS NIH NCI Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892, USA
    Breast Cancer Res Treat 88:149-59. 2004
    ..Incidence patterns are well-established for invasive breast carcinoma (InvBC) overall and for InvBC defined by estrogen receptor (ER) expression, but are not as well-defined for breast carcinoma in situ (CIS)...
  47. pmc Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
    Hazel B Nichols
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Clin Oncol 29:1564-9. 2011
    ..Contralateral breast cancer (CBC) is the most frequent new malignancy among women diagnosed with a first breast cancer. Although temporal trends for first breast cancers have been well studied, trends for CBC are not so well established...
  48. pmc Rising melanoma incidence rates of the trunk among younger women in the United States
    Porcia T Bradford
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20852, USA
    Cancer Epidemiol Biomarkers Prev 19:2401-6. 2010
    ..Therefore, we examined melanoma incidence trends by age, gender, and body site. Descriptive methods were complemented with the age-period-cohort parameters net drift and longitudinal age trend...
  49. pmc Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute
    Kenneth W Hance
    Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services, Washington, DC, USA
    J Natl Cancer Inst 97:966-75. 2005
    ..We examined incidence and survival trends for IBC in Surveillance, Epidemiology, and End Results (SEER) Program data with a case definition designed to capture many of its unique clinical and pathologic characteristics...
  50. ncbi request reprint Chemoprevention of colorectal carcinogenesis
    Asad Umar
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Int J Clin Oncol 7:2-26. 2002
    ..These targets will help identify more effective and better tolerated preventive agents. Carcinogenesis is now recognized as a disease in itself and has become the target of an ever-expanding array of preventive interventions...
  51. pmc Proportional hazards models and age-period-cohort analysis of cancer rates
    Philip S Rosenberg
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852 7244, USA
    Stat Med 29:1228-38. 2010
    ..The examples illustrate that each type of proportionality may be encountered in practice...
  52. pmc Age-specific trends in incidence of noncardia gastric cancer in US adults
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852, USA
    JAMA 303:1723-8. 2010
    ..For the last 50 years, overall age-standardized incidence rates for noncardia gastric cancer have steadily declined in most populations. However, overall rates are summary measures that may obscure important age-specific trends...
  53. pmc AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?
    Mercy Guech-Ongey
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 116:5600-4. 2010
    ..2-0.6]). The bimodal peaks for BL, in contrast to non-BL NHL, suggest effects of noncumulative risk factors at different ages. Underascertainment or biological reasons may account for BL deficit at low CD4 lymphocyte counts...
  54. ncbi request reprint Geographic variation in breast cancer mortality for white and black women: 1986-1995
    M T Canto
    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    CA Cancer J Clin 51:367-70. 2001
    ..The disparities in mortality rates by state likely depend on the stage of disease at diagnoses, socioeconomic status, access to care, and adequacy of medical care...
  55. doi request reprint Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas
    Philip M Grimley
    Department of Pathology, F Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA
    Cancer Epidemiol Biomarkers Prev 18:2256-61. 2009
    ....
  56. ncbi request reprint The role of cyclooxygenase inhibitors in cancer prevention
    William F Anderson
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Room 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Curr Pharm Des 8:1035-62. 2002
    ..Nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX) -1 and -2 are among the most promising classes of agents for targeted molecular prevention...
  57. ncbi request reprint Global trends in breast cancer incidence and mortality 1973-1997
    Michelle D Althuis
    Hormone and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS MSC 7234, Rockville, MD 20852, USA
    Int J Epidemiol 34:405-12. 2005
    ..Worldwide, breast cancer is the most common cancer and is the leading cause of cancer death among women...
  58. ncbi request reprint Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer
    J R McLachlin
    Laboratory of Molecular Hematology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892
    J Natl Cancer Inst 82:1260-3. 1990
    ..These results may serve as a model for the generation and selection of bone marrow cells resistant to the toxic effects of chemotherapeutic agents in vivo...
  59. doi request reprint Qualitative age-interactions in breast cancer: a tale of two diseases?
    Ismail Jatoi
    Department of Surgery, National Naval Medical Center and The Uniformed Services University, Bethesda, MD 20889, USA
    Am J Clin Oncol 31:504-6. 2008
    ..Taken together, these qualitative age-interactions may indicate that early and late-onset breast cancers are different diseases, derived from different pathways...
  60. ncbi request reprint A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
    Janice M Walshe
    Breast Cancer Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20889, USA
    Breast Cancer Res Treat 103:177-83. 2007
    ..To determine the long-term overall survival of male patients with stage II node positive breast cancer treated with adjuvant chemotherapy...
  61. ncbi request reprint Human gene therapy: why draw a line?
    W F Anderson
    Laboratory of Molecular Hematology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892
    J Med Philos 14:681-93. 1989
    ..Legitimate concerns about the potential for misuse of gene transfer technology justify drawing a moral line that includes corrective germline therapy but excludes enhancement interventions in both somatic and germline contexts...
  62. ncbi request reprint Development of COX inhibitors in cancer prevention and therapy
    Asad Umar
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, Bethesda, Maryland 20892 7317, USA
    Am J Clin Oncol 26:S48-57. 2003
    ..Discovering how to apply NSAIDs in persons with-or at risk for-cancer, although challenging, has the potential for considerable clinical and public health benefits...
  63. ncbi request reprint Cyclooxygenase inhibition in cancer prevention and treatment
    William F Anderson
    Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, EPN, Room 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Expert Opin Pharmacother 4:2193-204. 2003
    ..A brief discussion on the pharmacoeconomic considerations of NSAID and COXIB use and safety issues that have recently been the focus of debate, will be presented...
  64. ncbi request reprint Secondary chemoprevention of upper aerodigestive tract tumors
    W F Anderson
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892-7322, USA
    Semin Oncol 28:106-20. 2001
    ..Chemoprevention is a promising new technology, but is not currently standard therapy for the secondary prevention of UADT tumors...
  65. doi request reprint Management of women who have a genetic predisposition for breast cancer
    Ismail Jatoi
    Breast Care Center, National Naval Medical Center, Uniformed Services University, 8901 Wisconsin Avenue, Bethesda, MD 20889, USA
    Surg Clin North Am 88:845-61, vii-viii. 2008
    ..All patients should be informed that screening, prophylactic surgery, and chemoprevention have the potential for harm as well as benefit...
  66. ncbi request reprint In brief
    Ismail Jatoi
    Department of Surgery, National Naval Medical Center, Uniformed Services University, Bethesda, MD, USA
    Curr Probl Surg 42:616-8. 2005
  67. ncbi request reprint Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world
    Farin Kamangar
    Nutritional Epidemiology and Biostatistics Branches, Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852 7244, USA
    J Clin Oncol 24:2137-50. 2006
    ..For the eight most common cancers, priorities for reducing cancer disparities are discussed...
  68. ncbi request reprint Ductal carcinoma in situ of the breast
    William F Anderson
    N Engl J Med 351:399-402; author reply 399-402. 2004
  69. doi request reprint Increasing breast cancer incidence in China: the numbers add up
    Regina G Ziegler
    J Natl Cancer Inst 100:1339-41. 2008
  70. ncbi request reprint Delayed benefit of mammography screening in premenopausal women
    Ismail Jatoi
    J Clin Oncol 22:4860; author reply 4860-2. 2004
  71. ncbi request reprint Breast carcinoma in men
    William F Anderson
    Cancer 103:432-3; author reply 433. 2005
  72. ncbi request reprint Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
    Scott D Solomon
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    N Engl J Med 352:1071-80. 2005
    ..Experimental research suggesting that these drugs may contribute to a prothrombotic state provides support for this concern...
  73. ncbi request reprint Inter- and intra-ethnic differences for female breast carcinoma incidence in the continental United States and in the state of Hawaii
    Megan Fong
    School of Public Health and Health Sciences, George Washington University, Washington, DC, USA
    Breast Cancer Res Treat 97:57-65. 2006
    ..Ethnic diversity is well-documented for female breast carcinoma incidence in the continental US but is not so well-established in the state of Hawaii...
  74. ncbi request reprint Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002)
    Kimberly Irby
    School of Public Health and Health Sciences, The George Washington University, Washington, DC, USA
    Cancer Epidemiol Biomarkers Prev 15:792-7. 2006
    ..Colorectal carcinoma (CRC) is the fourth most common cancer diagnosed and the second most common cause of cancer death in the U.S. Incidence and mortality rates have decreased since the mid-1980s, although more among Whites than Blacks...
  75. ncbi request reprint Breast cancer heterogeneity: a mixture of at least two main types?
    William F Anderson
    J Natl Cancer Inst 98:948-51. 2006
  76. ncbi request reprint Celecoxib for the prevention of sporadic colorectal adenomas
    Monica M Bertagnolli
    Brigham and Women s Hospital, Boston, USA
    N Engl J Med 355:873-84. 2006
    ....
  77. ncbi request reprint Population-based analysis of pathologic data: a new approach to the investigation of uterine endometrial and ovarian endometrioid carcinomas
    Donald Earl Henson
    George Washington University Cancer Institute, Ross Hall, Room 502, 2300 Eye St, NW, Washington, DC 20037, USA
    Arch Pathol Lab Med 131:1337-42. 2007
    ....
  78. ncbi request reprint Absolute risk models for subtypes of breast cancer
    Mitchell H Gail
    J Natl Cancer Inst 99:1657-9. 2007
  79. doi request reprint Racial differences in breast cancer trends in the United States (2000-2004)
    Ruth M Pfeiffer
    J Natl Cancer Inst 100:751-2. 2008
  80. ncbi request reprint Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system
    Graca M Dores
    J Clin Oncol 23:7246-8. 2005
  81. doi request reprint Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States
    Graca M Dores
    Arch Dermatol 144:413-4. 2008
  82. ncbi request reprint Permanent paralysis of the right phrenic nerve
    James E Reeves
    Ann Intern Med 137:551-2. 2002
  83. ncbi request reprint Puberty and genetic susceptibility to breast cancer
    William F Anderson
    N Engl J Med 349:1088-9; author reply 1088-9. 2003
  84. ncbi request reprint Oophorectomy in carriers of BRCA mutations
    William F Anderson
    N Engl J Med 347:1037-40; author reply 1037-40. 2002